74P - Phase I expansion cohort results of cemiplimab, a human PD-1 monoclonal antibody, in combination with radiotherapy (RT), cyclophosphamide and GM-CSF, in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC)
| Autor: | Babiker, H.M., Brana, I., Mahadevan, D., Owonikoko, T.K., Calvo, E., Rischin, D., Moreno, V., Papadopoulos, K.P., Crittenden, M., Formenti, S., Giralt, J., Garrido, P., Hervás Morón, A., Mohan, K.K., Fury, M.G., Lowy, I., Stankevich, E., Feng, M., Li, J., Mathias, M. |
|---|---|
| Zdroj: | In Annals of Oncology December 2018 29 Supplement 10:x27-x27 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|